# CAR T Cells to Target GD2 for DMG

> **NCT05544526** · PHASE1 · RECRUITING · sponsor: **University College, London** · enrollment: 12 (estimated)

## Conditions studied

- Diffuse Midline Glioma, H3 K27M-Mutant

## Interventions

- **BIOLOGICAL:** GD2 CAR T cells

## Key facts

- **NCT ID:** NCT05544526
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-15
- **Primary completion:** 2025-12
- **Final completion:** 2039-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05544526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05544526, "CAR T Cells to Target GD2 for DMG". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05544526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*